MSH2 MUTATIONS AND BLADDER CANCER RISK: FAMILY MEMBERS OF HEREDITARY NONPOLYPOSIS COLORECTAL CANCER (HNPCC) PATIENTS WITH MSH2 MUTATIONS ARE AT INCREASED RISK NOT ONLY FOR UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA (TCC) BUT ALSO BLADDER CANCER